← MOLECULAR PARTNERS AG
| Annual Trend | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $20.4m |
$9.3m
-54.16%
|
$9.8m
+4.39%
|
$189.6m
+1843.82%
|
$7.0m
-96.29%
|
$5.0m
-29.38%
|
$0
-100.00%
|
$0 | |
| Revenues from research and development collaborations | $20.4m | $9.3m | $9.3m | $189.6m | $7.0m | $5.0m | $0 | — | |
| Net Interest Income | — | — | — | $523k |
$4.2m
+708.80%
|
$3.3m
-20.90%
|
$1.5m
-55.50%
|
$1.2m
-22.03%
|
|
| Research and development | $43.5m | $56.1m | $55.7m | $50.7m | $48.8m | $48.6m | $40.2m | $37.7m | |
| Selling, General and Administrative Expense | $13.5m | $11.6m | $17.5m | $22.2m | $19.4m | $17.6m | $15.2m | $14.6m | |
| Restructuring And Mergern Acquisition | — | — | — | — | $0 | $0 | $2.7m | $2.7m | |
| Restructuring expenses | — | — | — | — | $0 | $0 | ($2.7m) | — | |
| Operating expenses: | |||||||||
| Other Operating Expenses | — | — | ($424k) | ($44k) | — | — | — | — | |
| Total operating expenses | ($57.0m) | ($67.7m) | ($73.2m) | ($73.0m) | ($68.1m) | ($66.2m) | ($58.1m) | $52.7m | |
| EBIT | $118.5m | ($62.0m) | ($54.0m) | ($61.6m) | ($58.0m) | ||||
| Interest Expense On Lease Liabilities | — | $24k | $53k | $43k | $34k | $24k | $18k | $20k | |
| Interest Expense | — | — | — | $605k | $34k | $25k | $18k | $20k | |
| Interest Income | — | — | — | $1.1m | $4.3m | $3.4m | $1.5m | $1.2m | |
| Net Non Operating Interest Income Expense | — | — | — | $523k | $4.2m | $3.3m | $1.5m | $1.2m | |
| Gain On Sale Of Security | — | — | — | $717k | ($5.1m) | $3.8m | ($5.0m) | ($3.8m) | |
| Other Income | — | $0 | $424k | $44k | $0 | $0 | — | — | |
| Other Income Expense | — | — | — | $717k | ($5.1m) | $3.8m | ($7.7m) | ($6.4m) | |
| Result before income taxes | ($36.3m) | ($62.8m) | ($63.8m) | $117.9m | ($62.0m) | ($54.0m) | ($61.6m) | — | |
| Pre-Tax Income | ($36.3m) | ($62.8m) | ($63.8m) | $117.9m | ($62.0m) | ($54.0m) | ($61.6m) | ($58.0m) | |
| Income taxes | ($17k) | $11k | ($2k) | $0 | $0 | ($2k) | ($2k) | — | |
| Net Income From Continuing And Discontinued Operation | ($36.3m) | ($62.8m) | ($63.8m) | $117.9m | ($62.0m) | ($54.0m) | ($61.7m) | ($58.0m) | |
| Basic Earnings (Loss) Per Share | ($1.69) | ($2.51) | ($2.06) | $3.63 | ($1.89) | ($1.59) | ($1.65) | ($1.55) | |
| Diluted Earnings (Loss) Per Share | ($1.69) | ($2.51) | ($2.06) | $3.54 | ($1.89) | ($1.59) | ($1.65) | ($1.55) | |
| Basic Average Shares | — | — | — | $32.5m | $32.8m | $34.0m | $37.3m | $37.4m | |
| Diluted Average Shares | — | — | — | $33.3m | $32.8m | $34.0m | $37.3m | $37.4m | |
| Additional Financial Items | |||||||||
| Applicable Tax Rate | — | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| Average Effective Tax Rate | — | — | — | — | — | — | $0 | — | |
| Depreciation Right of Use Assets | — | $1.3m | $1.2m | $1.2m | $1.2m | $1.2m | $1.2m | $371k | |
| Finance Income | $1.6m | $367k | $191k | $1.9m | $4.3m | $7.2m | $1.5m | — | |
| Profit Loss Before Tax | ($36.3m) | ($62.8m) | ($63.8m) | $117.9m | ($62.0m) | ($54.0m) | ($61.6m) | — | |
| Profit Loss From Operating Activities | ($36.7m) | ($58.3m) | ($63.4m) | $116.6m | ($61.1m) | ($61.2m) | ($58.1m) | — | |
| Operating result | ($36.7m) | ($58.3m) | ($63.4m) | $116.6m | ($61.1m) | ($61.2m) | ($58.1m) | — | |
| Financial income | $1.6m | $367k | $191k | $1.9m | $4.3m | $7.2m | $1.5m | — | |
| Net finance result | $389k | ($4.4m) | ($365k) | $1.2m | ($876k) | $7.2m | ($3.5m) | — | |
| Net result, attributable to shareholders | ($36.3m) | ($62.8m) | ($63.8m) | $117.9m | ($62.0m) | ($54.0m) | ($61.7m) | — | |
| Remeasurement of net pension liabilities | ($4.7m) | ($1.5m) | $8.0m | $5.3m | ($2.0m) | ($485k) | ($3.8m) | — | |
| Exchange differences on translating foreign operations | ($14k) | ($26k) | ($3k) | ($17k) | ($16k) | ($10k) | $5k | — | |
| Other comprehensive result, net of tax | ($4.7m) | ($1.5m) | $8.0m | $5.3m | ($2.0m) | ($495k) | ($3.8m) | — | |
| Depreciation Amortization Depletion Income Statement | — | — | — | $416k | $367k | $419k | $371k | $371k | |
| Depreciation And Amortization In Income Statement | — | — | — | $416k | $367k | $419k | $371k | $371k | |
| Diluted EPS | ($1.69) | ($2.51) | ($2.06) | $3.54 | ($1.89) | ($1.59) | ($1.65) | ($1.55) | |
| Diluted NI Availto Com Stockholders | ($36.3m) | ($62.8m) | ($63.8m) | $117.9m | ($62.0m) | ($54.0m) | ($61.7m) | ($58.0m) | |
| Normalized EBITDA | — | — | — | $120.1m | ($54.4m) | ($55.5m) | ($51.8m) | ($55.9m) | |
| Normalized Income | — | — | — | $117.3m | ($57.9m) | ($57.5m) | ($54.6m) | ($54.2m) | |
| Other Gand A | — | — | — | $10.0m | $7.4m | $6.2m | $5.1m | — | |
| Reconciled Depreciation | — | — | — | $2.4m | $2.4m | $2.4m | $2.1m | $371k | |
| Salaries And Wages | — | — | — | $11.8m | $11.6m | $11.0m | $9.8m | $9.8m | |
| Selling General And Administration | — | — | — | $21.8m | $19.0m | $17.2m | $14.9m | — | |
| Special Income Charges | — | — | — | — | $0 | $0 | ($2.7m) | ($2.7m) | |
| Tax Effect Of Unusual Items | — | — | — | $139k | ($985k) | $326k | ($655k) | ($2.6m) | |
| Tax Provision | — | — | — | $0 | $0 | $2k | $2k | $4k | |
| Tax Rate For Calcs | — | — | — | $0 | $0 | $0 | $0 | $0 | |
| Employee Benefits Expense | — | $33.6m | $36.3m | $39.9m | $40.0m | $37.7m | $37.4m | — | |
| Expense From Share-Based Payment Transactions With Employees | — | $2.9m | $4.1m | $5.1m | $5.2m | $4.1m | $4.3m | — | |
| Expense Relating To Short-Term Leases For Which Recognition Exemption Has Been Used | — | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| Finance Costs | — | $4.8m | $556k | $619k | $5.2m | $38k | $5.0m | — | |
| Other Employee Expense | — | $1.7m | $663k | $1.5m | $3.0m | $2.6m | $2.5m | — | |
| Other Finance Cost | — | $9k | $8k | $14k | $15k | $13k | $15k | — | |
| Postemployment Benefit Expense Defined Benefit Plans | — | $3.1m | $3.1m | $3.2m | $2.6m | $1.5m | $1.6m | — | |
| Financial expenses | ($1.2m) | ($4.8m) | ($556k) | ($619k) | ($5.2m) | ($38k) | ($5.0m) | — | |
| Operating Expense | — | — | — | $72.9m | $68.1m | $66.2m | $55.4m | $52.7m | |
| Net Foreign Exchange Loss | — | $4.5m | $0 | $0 | $5.1m | $0 | $5.0m | — | |
| Total comprehensive result, attributable to shareholders | ($41.0m) | ($64.3m) | ($55.8m) | $123.2m | ($64.0m) | ($54.5m) | ($65.5m) | — | |
| Total Unusual Items | — | — | — | $717k | ($5.1m) | $3.8m | ($7.7m) | ($6.4m) | |
| Total Expenses | — | — | — | $72.9m | $68.1m | $66.2m | $55.4m | $52.7m |